147 related articles for article (PubMed ID: 2106278)
1. Treatment with gammaglobulin preparation for intravenous use in children with humoral immunodeficiency: clinical and immunologic follow-up.
Galli E; Barbieri C; Cantani A; Solano A; Longhi MA; Businco L
Ann Allergy; 1990 Feb; 64(2 Pt 1):147-50. PubMed ID: 2106278
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of treatment of children with hypogammaglobulinemia: comparison of fresh plasma and intravenous immunoglobulin preparation.
Bernatowska E; Weremowicz R; Janowicz W; Madaliński K
Arch Immunol Ther Exp (Warsz); 1986; 34(4):377-84. PubMed ID: 3099724
[TBL] [Abstract][Full Text] [Related]
3. [Deficiency in immunoglobulin subclasses as cause of increased infection susceptibility--a family study].
Grob M; Joller-Jemelka HI; Grob PJ
Schweiz Med Wochenschr; 1991 Feb; 121(5):133-44. PubMed ID: 1900641
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of primary immunodeficiencies with intravenous gamma globulin].
García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G
An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892
[TBL] [Abstract][Full Text] [Related]
5. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies.
Abrahamsen TG; Sandersen H; Bustnes A
Pediatrics; 1996 Dec; 98(6 Pt 1):1127-31. PubMed ID: 8951264
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
Bayrakci B; Ersoy F; Sanal O; Kiliç S; Metin A; Tezcan I
Turk J Pediatr; 2005; 47(3):239-46. PubMed ID: 16250308
[TBL] [Abstract][Full Text] [Related]
7. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
[TBL] [Abstract][Full Text] [Related]
9. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
Orange JS; Grossman WJ; Navickis RJ; Wilkes MM
Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approach.
Jolles S; Sleasman JW
Adv Ther; 2011 Jul; 28(7):521-33. PubMed ID: 21681653
[TBL] [Abstract][Full Text] [Related]
11. A prospective controlled crossover trial of a new presentation (10% vs. 5%) of a heat-treated intravenous immunoglobulin.
Matamoros N; De Gracia J; Hernández F; Pons J; Alvarez A; Jiménez V
Int Immunopharmacol; 2005 Mar; 5(3):619-26. PubMed ID: 15683857
[TBL] [Abstract][Full Text] [Related]
12. [The use of human gamma globulin in the treatment of common variable immunodeficiency].
de Gracia J; Vendrell M; Guarner L; Vidal R; Miravitlles M; Mayordomo C; Morell F
Med Clin (Barc); 1995 Feb; 104(6):201-6. PubMed ID: 7534366
[TBL] [Abstract][Full Text] [Related]
13. Home self-administration of intravenous immunoglobulin therapy in children.
Kobayashi RH; Kobayashi AD; Lee N; Fischer S; Ochs HD
Pediatrics; 1990 May; 85(5):705-9. PubMed ID: 2109852
[TBL] [Abstract][Full Text] [Related]
14. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency.
Kutukculer N; Karaca NE; Demircioglu O; Aksu G
Pediatr Allergy Immunol; 2007 Mar; 18(2):167-73. PubMed ID: 17338791
[TBL] [Abstract][Full Text] [Related]
15. The long term treatment of childhood hypogammaglobulinaemia in Melbourne with intravenous gammaglobulin, 1972-1985.
Roberton DM; Hosking CS
Dev Biol Stand; 1987; 67():273-80. PubMed ID: 2440742
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
[TBL] [Abstract][Full Text] [Related]
17. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
Nettagul R; Visitsunthorn N; Vichyanond P
J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin therapy for antibody deficiency.
Nolte MT; Pirofsky B; Gerritz GA; Golding B
Clin Exp Immunol; 1979 May; 36(2):237-43. PubMed ID: 477026
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous immunoglobulin administration for antibody deficiency (author's transl)].
Luthardt T
Dtsch Med Wochenschr; 1980 Jul; 105(28):993-7. PubMed ID: 7408694
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysis.
Shapiro RS
Ann Allergy Asthma Immunol; 2013 Jul; 111(1):51-5. PubMed ID: 23806460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
